Categories
· Business (Tobacco)
Organizations
· RJR
· Targacept
|
Jump to full article: Business Wire, 2000-08-25
Intro: Listen to RadioWallStreet.com's interview with Targacept, Inc. President/CEO, J. Donald de Bethizy.
He discusses the mission of the new RJ Reynolds spinoff as a privately held R&D pharmaceutical company. Targecept will develop compounds to treat major disorders such as ulcerative colitis and Alzheimer's disease. . .
If you are viewing this release after the day of the event, go to http://www.radiowallstreet.com/NASApp/RWS/EventPage?ID=36901.
Jump to full article » |